A citation-based method for searching scientific literature

Robert K Abbott, Jeong Hyun Lee, Sergey Menis, Patrick Skog, Meghan Rossi, Takayuki Ota, Daniel W Kulp, Deepika Bhullar, Oleksandr Kalyuzhniy, Colin Havenar-Daughton, William R Schief, David Nemazee, Shane Crotty. Immunity 2018
Times Cited: 166







List of co-cited articles
1412 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


De novo protein design by deep network hallucination.
Ivan Anishchenko, Samuel J Pellock, Tamuka M Chidyausiku, Theresa A Ramelot, Sergey Ovchinnikov, Jingzhou Hao, Khushboo Bafna, Christoffer Norn, Alex Kang, Asim K Bera,[...]. Nature 2021
26
3


Designing chimeric antigen receptors to effectively and safely target tumors.
Michael C Jensen, Stanley R Riddell. Curr Opin Immunol 2015
104
1

Protein delivery using engineered virus-like particles.
Stanislaw J Kaczmarczyk, Kalavathy Sitaraman, Howard A Young, Stephen H Hughes, Deb K Chatterjee. Proc Natl Acad Sci U S A 2011
126
1

Controlled aggregation of ferritin to modulate MRI relaxivity.
Kevin M Bennett, Erik M Shapiro, Christopher H Sotak, Alan P Koretsky. Biophys J 2008
34
2

Introduction of Surface Loops as a Tool for Encapsulin Functionalization.
Sandra Michel-Souzy, Naomi M Hamelmann, Sara Zarzuela-Pura, Jos M J Paulusse, Jeroen J L M Cornelissen. Biomacromolecules 2021
2
50

In vitro self-assembly of tailorable nanotubes from a simple protein building block.
Edward R Ballister, Angela H Lai, Ronald N Zuckermann, Yifan Cheng, Joseph D Mougous. Proc Natl Acad Sci U S A 2008
205
1


Structure-based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeae.
Liqin Wang, Daniel Xing, Adriana Le Van, Ann E Jerse, Shuishu Wang. FEBS Open Bio 2017
11
9

Development of a general defined medium for Pichia pastoris.
Catherine B Matthews, Angel Kuo, Kerry R Love, J Christopher Love. Biotechnol Bioeng 2018
30
3

Development of the vault particle as a platform technology.
Leonard H Rome, Valerie A Kickhoefer. ACS Nano 2013
56
1

Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate.
Kevin J Hamblett, Peter D Senter, Dana F Chace, Michael M C Sun, Joel Lenox, Charles G Cerveny, Kim M Kissler, Starr X Bernhardt, Anastasia K Kopcha, Roger F Zabinski,[...]. Clin Cancer Res 2004
724
1

Virus-Inspired Polymer for Efficient In Vitro and In Vivo Gene Delivery.
Yilong Cheng, Roma C Yumul, Suzie H Pun. Angew Chem Int Ed Engl 2016
67
1

A fragment-based protein interface design algorithm for symmetric assemblies.
Joshua Laniado, Kyle Meador, Todd O Yeates. Protein Eng Des Sel 2021
2
50

Principles of nanoparticle design for overcoming biological barriers to drug delivery.
Elvin Blanco, Haifa Shen, Mauro Ferrari. Nat Biotechnol 2015
1

RTS,S/AS01 vaccine (Mosquirix™): an overview.
Matthew B Laurens. Hum Vaccin Immunother 2020
65
1

A smart viral vector for targeted delivery of hydrophobic drugs.
Sukanya Ghosh, Manidipa Banerjee. Sci Rep 2021
6
16

Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens.
Benjamin J Read, Lori Won, John C Kraft, Isaac Sappington, Aereas Aung, Shengwei Wu, Julia Bals, Chengbo Chen, Kelly K Lee, Daniel Lingwood,[...]. Cell Rep 2022
1
100

Fibroin nanoparticles: a promising drug delivery system.
Duy Toan Pham, Waree Tiyaboonchai. Drug Deliv 2020
34
2

F-domain valency determines outcome of signaling through the angiopoietin pathway.
Yan Ting Zhao, Jorge A Fallas, Shally Saini, George Ueda, Logeshwaran Somasundaram, Ziben Zhou, Infencia Xavier Raj, Chunfu Xu, Lauren Carter, Samuel Wrenn,[...]. EMBO Rep 2021
4
25

The coming of age of de novo protein design.
Po-Ssu Huang, Scott E Boyken, David Baker. Nature 2016
550
1

Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation.
Tetiana Melnyk, Snežana Đorđević, Inmaculada Conejos-Sánchez, María J Vicent. Adv Drug Deliv Rev 2020
16
6

Bispecific antibody based therapeutics: Strengths and challenges.
Archana Thakur, Manley Huang, Lawrence G Lum. Blood Rev 2018
61
1

Targeting dendritic cells with biomaterials: developing the next generation of vaccines.
Sai T Reddy, Melody A Swartz, Jeffrey A Hubbell. Trends Immunol 2006
294
1


Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health.
Chelsea N Fries, Elizabeth J Curvino, Jui-Lin Chen, Sallie R Permar, Genevieve G Fouda, Joel H Collier. Nat Nanotechnol 2021
45
2

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.
Justin Eyquem, Jorge Mansilla-Soto, Theodoros Giavridis, Sjoukje J C van der Stegen, Mohamad Hamieh, Kristen M Cunanan, Ashlesha Odak, Mithat Gönen, Michel Sadelain. Nature 2017
803
1

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Steven Horwitz, Owen A O'Connor, Barbara Pro, Tim Illidge, Michelle Fanale, Ranjana Advani, Nancy L Bartlett, Jacob Haaber Christensen, Franck Morschhauser, Eva Domingo-Domenech,[...]. Lancet 2019
279
1

Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species.
Mohammadsharif Tabebordbar, Kim A Lagerborg, Alexandra Stanton, Emily M King, Simon Ye, Liana Tellez, Allison Krunnfusz, Sahar Tavakoli, Jeffrey J Widrick, Kathleen A Messemer,[...]. Cell 2021
28
3

De novo peptide grafting to a self-assembling nanocapsule yields a hepatocyte growth factor receptor agonist.
Yamato Komatsu, Naohiro Terasaka, Katsuya Sakai, Emiko Mihara, Risa Wakabayashi, Kunio Matsumoto, Donald Hilvert, Junichi Takagi, Hiroaki Suga. iScience 2021
2
50

The Influence of Nanoparticle Shape on Protein Corona Formation.
Rahul Madathiparambil Visalakshan, Laura E González García, Mercy R Benzigar, Arthur Ghazaryan, Johanna Simon, Agnieszka Mierczynska-Vasilev, Thomas D Michl, Ajayan Vinu, Volker Mailänder, Svenja Morsbach,[...]. Small 2020
43
2

Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins.
Samagya Banskota, Aditya Raguram, Susie Suh, Samuel W Du, Jessie R Davis, Elliot H Choi, Xiao Wang, Sarah C Nielsen, Gregory A Newby, Peyton B Randolph,[...]. Cell 2022
19
5

Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.
M Anthony Moody, Feng Gao, Thaddeus C Gurley, Joshua D Amos, Amit Kumar, Bhavna Hora, Dawn J Marshall, John F Whitesides, Shi-Mao Xia, Robert Parks,[...]. Cell Host Microbe 2015
51
1

Improving the expression of recombinant soluble HIV Envelope glycoproteins using pseudo-stable transient transfection.
George Sellhorn, Zachary Caldwell, Christine Mineart, Leonidas Stamatatos. Vaccine 2009
40
2

Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins.
George Sellhorn, Zane Kraft, Zachary Caldwell, Katharine Ellingson, Christine Mineart, Michael S Seaman, David C Montefiori, Eliza Lagerquist, Leonidas Stamatatos. J Virol 2012
22
4

Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy.
Andrew Hiatt, Natasha Bohorova, Ognian Bohorov, Charles Goodman, Do Kim, Michael H Pauly, Jesus Velasco, Kevin J Whaley, Pedro A Piedra, Brian E Gilbert,[...]. Proc Natl Acad Sci U S A 2014
73
1

Selective cytotoxicity of a novel immunotoxin based on pulchellin A chain for cells expressing HIV envelope.
Mohammad Sadraeian, Francisco E G Guimarães, Ana P U Araújo, David K Worthylake, Louis Jr LeCour, Seth H Pincus. Sci Rep 2017
11
9

HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
Xiaoying Shen, Fatima Laher, Zoe Moodie, Arthur S McMillan, Rachel L Spreng, Peter B Gilbert, Ying Huang, Nicole L Yates, Nicole Grunenberg, M Juliana McElrath,[...]. Sci Rep 2020
10
10

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial.
Joel V Chua, Charles Davis, Jennifer S Husson, Amy Nelson, Ilia Prado, Robin Flinko, Ka Wing J Lam, Lydiah Mutumbi, Bryan T Mayer, Dan Dong,[...]. Vaccine 2021
1
100

Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches.
Shannon L Meeks, Glaivy Batsuli. Hematology Am Soc Hematol Educ Program 2016
37
2


Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
P Lind, K Larsson, J Spira, M Sydow-Bäckman, A Almstedt, E Gray, H Sandberg. Eur J Biochem 1995
100
1

The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development.
B M Reipert, B Gangadharan, C J Hofbauer, V Berg, H Schweiger, J Bowen, J Blatny, K Fijnvandraat, E S Mullins, J Klintman,[...]. Blood Adv 2020
9
11


Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.
Corien L Eckhardt, Alice S van Velzen, Marjolein Peters, Jan Astermark, Paul P Brons, Giancarlo Castaman, Marjon H Cnossen, Natasja Dors, Carmen Escuriola-Ettingshausen, Karly Hamulyak,[...]. Blood 2013
138
1

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.
Flora Peyvandi, Pier M Mannucci, Isabella Garagiola, Amal El-Beshlawy, Mohsen Elalfy, Vijay Ramanan, Peyman Eshghi, Suresh Hanagavadi, Ramabadran Varadarajan, Mehran Karimi,[...]. N Engl J Med 2016
280
1

Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice.
Bimba F Hoyer, Katrin Moser, Anja E Hauser, Anette Peddinghaus, Caroline Voigt, Dan Eilat, Andreas Radbruch, Falk Hiepe, Rudolf A Manz. J Exp Med 2004
338
1


Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A.
A Navarrete, S Dasgupta, S Delignat, G Caligiuri, O D Christophe, J Bayry, A Nicoletti, S V Kaveri, S Lacroix-Desmazes. J Thromb Haemost 2009
46
2

CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
Katharina N Steinitz, Pauline M van Helden, Brigitte Binder, David C Wraith, Sabine Unterthurner, Corinna Hermann, Maria Schuster, Rafi U Ahmad, Markus Weiller, Christian Lubich,[...]. Blood 2012
53
1


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.